1118-03-2

Basic information

• Product Name: AZIDOTRIMETHYLTIN
• Synonyms: AZIDOTRIMETHYLTIN;TrimeThylTin azide;azidotrimethyltin(iv);TRIMETHYLTINAZIDE=AZIDOTRIMETHYLTIN;Trimethyltinazide, 97% (CH3)3SnN3 F.W.205,82;trimethylstannanylium:azide
• CAS NO: 1118-03-2
• Molecular Formula: C₃H₉N₃Sn
• Molecular Weight: 205.83
• Product Categories: Azide SourcesOrganometallic Reagents;Chemical Ligation;Click Chemistry;Organotin;Organotins
• Mol File: 1118-03-2.mol

Chemical Properties

• Melting Point: 117-120 °C(lit.)
• Appearance: /
• CAS DataBase Reference: AZIDOTRIMETHYLTIN(CAS DataBase Reference)
• NIST Chemistry Reference: AZIDOTRIMETHYLTIN(1118-03-2)
• EPA Substance Registry System: AZIDOTRIMETHYLTIN(1118-03-2)

Safety Data

• Hazard Codes: T+,N
• Statements: 26/27/28-50/53
• Safety Statements: 26-27-28-45-60-61
• RIDADR: UN 3146 6.1/PG 2
• WGK Germany: 2
• Hazardous Substances Data: 1118-03-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
AZIDOTRIMETHYLTIN is used as a precursor in the synthesis of various organic compounds, playing a crucial role in the formation of organotin compounds and the alteration of organic molecules.
Used in Azide-Alkyne Cycloaddition Reactions:
In the field of chemical synthesis, AZIDOTRIMETHYLTIN is utilized as a reagent for azide-alkyne cycloaddition reactions, which are key processes in the creation of 1,2,3-triazole compounds, a class of molecules with diverse applications in chemistry and biology.
Used in Pharmaceutical and Chemical Research:
AZIDOTRIMETHYLTIN is employed in research settings for the development of new pharmaceutical agents and chemical entities, capitalizing on its unique reactivity and synthetic potential.

InChI:InChI=1/3CH3.N3.Sn/c;;;1-3-2;/h3*1H3;;/q;;;-1;+1/rC3H9N3Sn/c1-7(2,3)6-5-4/h1-3H3

Upstream product

• 1066-45-1 trimethyltin(IV)chloride 
• 4648-54-8 trimethylsilylazide 
• 1068-74-2 Diethylamino-trimethyl-stannan 

Downstream Products

• 348639-11-2 2-[1-methyl-5-(1-trimethylstannanyl-1H-tetrazol-5-yl)-1H-indol-3-yl]-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine 
• 55408-10-1 1H-tetrazole-5-carboxylic acid ethyl ester 
• 317828-51-6 2-[(S)-1-Phenylethylamino]-4-[5-(tetrazol-5-yl)benzimidazol-1-yl]pyrimidine 
• 337521-78-5 2-Methyl-1-(6-(1H-1H-1,2,3,4-tetrazol-5-yl)-2-naphthyl)-1-(1-trityl-1H-imidazol-4-yl)-1-propanol 
• 137419-91-1 7-Methyl-2-propyl-3-[4-(2-phenyl-2-(tetrazol-5-yl)ethyl)phenyl]methyl-3H-imidazo[4,5-b]pyridine 
• 61-82-5 3⁽⁵⁾-amino-1,2,4-triazole 
• 217325-94-5 N-(3,5-dichlorobenzenesulfonyl)-(L)-prolyl-(L)-4-(2'-(tetrazol-5-yl)phenyl)phenylalanine 
• 594-27-4 tetramethylstannane 
• 934-56-5 trimethyl(phenyl)stannane 
• 851671-58-4 (C6H3-2,6-(C6H3-2,6-iPr2)2)Ge(μ-NH2)2Ge(C6H3-2,6-(C6H3-2,6-iPr2)2) 
• 945602-85-7 tert-butyl methyl-{1-[({5-[3-(2H-tetrazol-5-yl)phenyl]pyridin-3-yl}oxy)methyl]cyclopropyl}carbamate 
• 1009367-63-8 tert-Butyl 3-(1 H-tetrazol-5-yl)azetidine-1-carboxylate 

Related news

Adsorption structure and doping effect of AZIDOTRIMETHYLTIN (cas 1118-03-2) on graphene09/09/2019

The adsorption structure and the electronic property of azidotrimethyltin (ATMT) on monolayer graphene were investigated using scanning tunneling microscopy and core-level photoemission spectroscopy. We also confirmed the n-type doping effect by scanning tunneling spectroscopy and work function ...detailed

Relevant articles and documents

Ein einfaches Verfahren zur Herstellung von Organozinnaziden. Synthese und Struktur der sterisch gehinderten Stannylazide tBu3SnN3 und tBu2Sn(N3)2

Sterically crowded stannyl azides tBunSn(N3)4-n (IIa,b) have been prepared for the first time by the reactions of stannylamines tBunSn(NHR)4-n (Ia,b) with Me3SiN3 (a: n = 3, R = H; b: n = 2, R = tBu).The novel compounds were characterized by NMR (1H, 13C) and mass spectroscopy and their molecular structure determined by X-ray crystallography (IIa: space group P21/m, Z = 2; IIb: space group P21/n, Z = 4). Keywords: Tin; Stannyl azides; Synthesis; X-ray structure

SUBSTITUTED PYRIDOPYRIMIDINONES AND RELATED HETEROCYCLES AS ANGIOTENSIN II ANTAGONISTS

Novel substituted pyridopyrimidinones of formula (I), which are useful as angiotensin II antagonists, are disclosed. STR1

Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists

Substituted Imidazo-fused 6-membered heterocycles of structural formula: STR1 wherein A, B, C, and D are independently carbon atoms or nitrogen atoms are angiotensin II antagonists useful in the treatment of hypertension and congestive heart failure.

IMIDAZOLE DERIVATIVES BEARING ACIDIC FUNCTIONAL GROUPS AT THE 5-POSITION, THEIR COMPOSITIONS AND METHODS OF USE AS ANGIOTENSIN II ANTAGONISTS

There are disclosed substituted imidazole derivatives of Formula I bearing acidic functional groups which are useful as angiotensin II antagonists. STR1

SUBSTITUTED PYRAZOLOPYRIMIDINES AS ANGIOTENSIN II ANTAGONISTS

Novel substituted pyrazolopyrimidines of formula (I) which are useful as angiotensin II antagonists, are disclosed. STR1

Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists

Novel substituted pyrazino[2,3-d]pyrimidinones of formula (I), are angiotensin II antagonists, useful in the treatment of hypertension and related disorders and in certain CNS disorders.

Substituted quinazolinones as angiotensin II antagonists

Novel substituted quinazolinones of the formula (I), which are useful as angiotensin II antagonists, are disclosed. STR1

MICROBIAL TRANSFORMATION PROCESS FOR PRODUCING AN ANTIHYPERTENSIVE PRODUCT

Fermentation of the microorganism Streptomyces sp. (MA6750) ATCC No. 55042 in the presence of the Angiotensin II (A II) receptor antagonist of the following structure: STR1 yields an analog having a shikimate sugar-like moiety attached to the tetrazole, the said analog which is also an A II antagonist useful in the treatment of hypertension and congestive heart failure and other indications known to respond to A II angatonists.

SUBSTITUTED IMIDAZO-FUSED 6-MEMBERED HETEROCYCLCES AS ANGIOTENSIN II ANTAGONISTS

Substituted Imidazo-fused 6-membered heterocycles of structural formula: STR1 wherein A, B, C, and D are independently carbon atoms or nitrogren atoms are angiotensin II antagonists useful in the treatment of hypertension and congestive heart failure.

Microbial transformation process for antihypertensive products

Fermentation of the microorganism Streptomyces sp. MA6751 (ATCC No. 55043) in the presence of the Angiotensin II (A II) receptor antagonist yields an N2-tetrazole β-glucuronide analog which is also an A II antagonist useful in the treatment of hypertension and congestive heart failure and other indications known to respond to A II antagonists.